Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 10,287.10%3.22M | 3.35M | 489K | -107.07%-2.86M | -138.28%-2.89M | -99.69%31K | 0 | 0 | -9.02%40.41M | -36.79%7.54M |
Net interest income | 712.90%252K | --387K | ---- | -47.18%21.31M | 182.15%21.28M | -99.69%31K | --0 | ---- | -9.17%40.34M | -36.79%7.54M |
-Net interest income | 712.90%252K | --391K | ---- | -49.77%22.24M | 155.54%22.21M | -99.72%31K | --0 | ---- | -11.07%44.27M | -29.77%8.69M |
-Total interest expense | ---- | --4K | ---- | -76.37%929K | ---- | ---- | --0 | ---- | -26.74%3.93M | 159.37%1.15M |
Non interest income | --2.97M | --2.96M | --489K | -36,712.12%-24.16M | ---24.16M | --0 | --0 | ---- | --66K | --0 |
-Other non interest income | --2.97M | --2.96M | --489K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Gain loss on sale of assets | ---- | ---- | ---- | -36,712.12%-24.16M | ---- | ---- | ---- | ---- | --66K | --0 |
Credit losses provision | 93.68%-2.57M | -581.61%-40.66M | -702.68%-17.38M | |||||||
Non interest expense | 107.75%3.67M | 147.55%3.98M | 283.13%5.75M | -52.17%15.52M | 78.65%10.64M | -81.73%1.77M | -78.11%1.61M | -84.16%1.5M | -5.68%32.45M | -35.76%5.96M |
Selling and administrative expenses | 22.87%2.14M | 61.63%2.57M | 154.67%3.76M | ---- | ---- | -81.78%1.75M | -78.06%1.59M | -84.18%1.48M | ---- | ---- |
-General and administrative expense | 21.66%2.12M | 60.87%2.55M | 154.67%3.76M | ---- | ---- | -81.43%1.75M | -77.03%1.59M | -83.13%1.48M | ---- | ---- |
-Selling and marketing expense | --21K | --12K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Depreciation amortization depletion | 2,177.27%501K | 2,177.27%501K | 327.27%94K | ---- | ---- | -77.32%22K | -81.03%22K | -82.40%22K | ---- | ---- |
-Depreciation and amortization | 2,177.27%501K | 2,177.27%501K | 327.27%94K | ---- | ---- | -77.32%22K | -81.03%22K | -82.40%22K | ---- | ---- |
Other non-interest expense | --1.03M | --917K | --1.89M | -52.17%15.52M | ---- | ---- | ---- | ---- | --32.45M | ---- |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 14K | 30K | 0 | 0 | ||||||
Less:Other special charges | ---14K | ---30K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -13.51%32K | -438.78%-264K | -3,583.33%-418K | 145K | 37K | -49K | 12K | |||
Income before tax | 76.16%-405K | 47.41%-872K | -281.45%-5.68M | 36.39%-20.8M | -1.02%-15.96M | 83.62%-1.7M | 59.85%-1.66M | 38.10%-1.49M | -908.26%-32.7M | -3,323.47%-15.8M |
Income tax | 60K | 103K | -128K | 0 | 0 | 0 | 0 | 0 | 35.21%1.42M | -98.36%2K |
Earnings from equity interest net of tax | ||||||||||
Net income | 98.40%-186K | 98.34%-174K | -324.23%-3.49M | 39.03%-20.8M | 98.66%-211K | 12.80%-11.66M | -230.55%-10.49M | 187.56%1.56M | -1,238.06%-34.12M | -4,392.66%-15.8M |
Net Income continuous operations | 72.63%-465K | 41.19%-975K | -272.85%-5.55M | 39.03%-20.8M | -1.01%-15.96M | 87.30%-1.7M | 47.73%-1.66M | 16.26%-1.49M | -1,238.06%-34.12M | -4,392.66%-15.8M |
Net income discontinuous operations | 102.80%279K | 109.07%801K | -32.36%2.06M | ---- | ---- | ---9.96M | ---8.83M | --3.04M | ---- | ---- |
Minority interest income | -62K | 277K | -211K | 0 | 0 | 0 | ||||
Net income attributable to the parent company | 98.94%-124K | 95.70%-451K | -310.67%-3.28M | 39.03%-20.8M | 98.66%-211K | 12.80%-11.66M | -230.55%-10.49M | 187.56%1.56M | -1,238.06%-34.12M | -4,392.66%-15.8M |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 98.94%-124K | 95.70%-451K | -310.67%-3.28M | 39.03%-20.8M | 98.66%-211K | 12.80%-11.66M | -230.55%-10.49M | 187.66%1.56M | -1,243.78%-34.12M | -4,416.12%-15.8M |
Basic earnings per share | 97.50%-0.04 | 95.14%-0.07 | -333.33%-0.49 | 38.49%-2.86 | 91.28%-0.19 | 13.51%-1.6 | -227.27%-1.44 | 187.50%0.21 | -1,292.31%-4.65 | -4,460.00%-2.18 |
Diluted earnings per share | 97.50%-0.04 | 95.14%-0.07 | -333.33%-0.49 | 38.49%-2.86 | 91.28%-0.19 | 13.51%-1.6 | -227.27%-1.44 | 187.50%0.21 | -1,292.31%-4.65 | -4,460.00%-2.18 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |